Avantgarde solutions in healthcare and pharma

Who we are

Oliba is a boutique consulting company that provides expert scientific advice and strategic guidance to healthcare, pharma and biotech companies across the globe.

Established in 2011, Oliba offers multidisciplinary perspectives on complex issues in drug and medical device development, including market access, strategic planning and implementation, stakeholder engagement, effective communications, and developing institutional relationships.

Our services

Scientific
and
strategic
consulting

Learn more

Healthcare,
pharma,
and biotech
innovation

Learn more

Communication
and
education
programs

Learn more

Recent
activities

Oliba is a boutique consulting company that provides expert scientific advice and strategic guidance to healthcare, pharma and biotech companies across the globe.

MIT study reveals non-invasive treatment holds promise for treating ‘chemo brain’

A study by MIT researchers demonstrates the potential of a non-invasive gamma treatment to mitigate "chemo brain," a condition associated with cognitive impairments in cancer patients undergoing chemotherapy. Initially aimed to treat Alzheimer's disease, this therapy uses light and sound at a 40-hertz frequency to stimulate brain waves. (Source: PharmaTimes)

Swedish researchers develop new AI computer model to detect lymphatic cancer

Swedish researchers at Chalmers University of Technology developed an AI model, named Lymphoma Artificial Reader System (LARS), that detects lymphatic cancer with 90% accuracy. This deep learning system, trained on over 17,000 images from more than 5,000 patients, assists radiologists by analyzing images from positron emission tomography to identify visual signs of cancer. (Source: PharmaTimes)

FDA approval could shape liver disease treatment landscape

The FDA has approved Rezdiffra (resmetirom) for the treatment of noncirrhotic non-alcoholic steatohepatitis (NASH), also known as fatty liver disease. This approval, under the FDA's Accelerated Approval program, is based on Phase III data showing Rezdiffra's efficacy in reducing fat accumulating in the liver. (Source: European Pharmaceutical Review)

Blood test for early Alzheimer’s detection

Researchers funded by the NIH have developed a method to detect toxic Aβ oligomers in patients’ blood, showing potential for early detection of Alzheimer's disease. Tested on nearly 400 human blood samples, this method offers a way to intervene before significant brain damage occurs, and could also be adapted to detect other neurodegenerative diseases like Parkinson's. (Source: NIH)

Stroke experts to test emerging nerve stimulation treatment

A new stroke therapy that delivers electrical pulses to the brain via a portable device will be tested in a pioneering trial to improve arm recovery after stroke. Led by researchers from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, this trial aims to determine if transcutaneous vagus nerve stimulation can enhance hand and arm strength during rehabilitation therapy for stroke survivors. (Source: PharmaTimes)

Scientific and
strategic consulting

Oliba collaborates with clients and specialists to analyze scientific, clinical, and commercial information, driving project success.

Panels and advisory boards

Oliba develops and manages board of patients or specialists to ensure successful products, campaigns, and projects of healthcare, pharma, and biotech companies.

Patient and
caregiver advocacy

Oliba acts as an intermediary between patients and caregivers with healthcare, pharma, and biotech organizations to facilitate the former‘s involvement in research and decision-making.

Regulatory
affairs

Oliba provides expert support in the design and implementation of innovative regulatory strategies to expedite product development, marketing authorization, and commercial distribution.

Institutional
relationships

Oliba provides strategic advice on the development and management of relationships between companies with regulatory authorities/key stakeholders to enable effective liaisons.

Healthcare projects
and partnerships

Oliba works closely with clients in developing scientific projects to completion, including identifying potential partners, funding sources, as well as legal aspects of partnerships.

Communication and
education programs

Using a data-driven, evidence-based approach, Oliba delivers effective communication strategies that are tailored to the client’s goals and target audiences.

Specialist scientific writing services

Oliba‘s expert scientific writers offer customized services, supported by access to latest research, to produce a range of high-quality scientific outputs, including reports, briefs, and peer-reviewed papers.

Digital and
in-person events

Oliba has extensive experience in organizing both digital and in-person events for professionals to network, learn about the latest developments, and collaborate with peers.

Seminars, workshops, and trainings

Oliba arranges seminars that offer in-depth learning, workshops that provide practical experience, and training programs that address specific educational requirements.